A new study released has indicated that Avastin as a treatment for advanced wet macular degeneration does not improve visual acuity. Developed a drug to treat cancer, Avastin has been used by many … [Read more...]
Difference Found in Avastin and Lucentis Treatment for Macular Degeneration
Avastin has been used for several years as a treatment for Macular Degeneration. While not an FDA approved treatment, Avastin was shown to not only halt the progression of wet macular degeneration, … [Read more...]
Radiation Therapy for Wet Macular Degeneration
The 18-month data from NeoVista's Phase II feasibility stufy examing its epiretinal brachytherapy for treatment of wet macular degeneration was revealed at the 41st scientific meeting of the Retina … [Read more...]
VEGF Trap-Eye: New Data Confirm Successes in the Treatment of Age-related Macular Degeneration
Berlin, Germany, September 28, 2008 – VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters in the formation of new blood vessels in the treatment of … [Read more...]
Avastin Improves Vision in Wet Macular Degeneration Patients
Avastin treatments have been shown to improve vision in patients with long term low vision secondary to wet macular degeneration. Designed initially as a cancer drug, Avastin has been used to treat … [Read more...]



Recent Comments